http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007186500-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b55c349b43c3ecba4977fd52cc8f8c67
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
filingDate 2006-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96107b6ab43c73e22c0271e1328af11c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7caea5b8b8eedf063e3b816dbf3b85e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89338901e6525a49177627dc5001d22c
publicationDate 2007-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2007186500-A
titleOfInvention Patch preparation
abstract [PROBLEMS] To develop a patch preparation that transdermally administers a drug that is liquid at or near room temperature into a living body, and in a patch preparation that uses a polyisobutylene-based adhesive as an adhesive, the bleeding of the drug can be suppressed. To provide a patch preparation having sufficient adhesive properties. A patch preparation 10 of the present invention has a pressure-sensitive adhesive layer 2 laminated on one side of a support 1. The pressure-sensitive adhesive layer 2 contains a branched monohydric alcohol having 12 to 28 carbon atoms, a drug that is liquid at or near room temperature (excluding the free base of bisoprolol), and a polyisobutylene-based pressure-sensitive adhesive. It is characterized by. Thereby, the compatibility with a polyisobutylene adhesive and a drug can be raised specifically. As a result, the compounding amount of the drug can be increased, the drug bleeding from the pressure-sensitive adhesive layer can be suppressed, and sufficient adhesive properties can be obtained in practical use. [Selection] Figure 1
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5925903-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160113120-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104703607-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015115497-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9789188-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104703607-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014057928-A1
priorityDate 2005-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4705343-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10892731
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2405
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410328
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410327

Total number of triples: 30.